TRDA
Entrada Therapeutics Inc
6.20$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Entrada Therapeutics Inc (TRDA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -32 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24 | -4.0 | -26 | 40 | -24 | -32 | -39 | -29 | -28 | -32 | -42 | -32 | -135 | |
| 0.8 | 0.7 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 1.0 | 1.2 | -2.8 | 0.8 | 0.8 | 0.1 | |
| 3.4 | 3.8 | 3.7 | 4.6 | 4.9 | 4.7 | 5.1 | 5.0 | 5.1 | 4.4 | 4.7 | 5.2 | 19 | |
| -62 | 3.0 | -52 | -18 | -13 | -36 | -26 | 8.5 | 10 | 2.4 | -7.0 | 4.8 | 10 | |
| 1.4 | 1.0 | 0.8 | 1.0 | 0.6 | 0.6 | 1.1 | 0.3 | 0.2 | 0.2 | 0.0 | 0.0 | 0.4 | |
| -3.7 | 19 | 26 | -24 | -83 | 53 | 4.8 | 34 | 49 | 29 | 27 | 55 | 160 | |
| – | 0.4 | – | – | 0.3 | – | – | 0.3 | – | 0.1 | – | 0.3 | – | |
| 0.4 | 0.7 | 0.2 | 101 | 0.0 | 1.4 | 0.4 | 0.3 | 0.0 | 0.2 | 0.1 | 0.4 | 0.7 | |
| -28 | 16 | 0.8 | 117 | -107 | 23 | -33 | 4.6 | 21 | -2.9 | -15 | 23 | 26 | |
| -26 | -5.0 | -26 | 39 | -25 | -32 | -40 | -30 | -28 | -32 | -42 | -32 | -134 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.